Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Daiichi Sankyo Nordics ApS - Sweden Filial
UJP
Active
Org 5164113697
Linneavägen 4, 181 60
Lidingö
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2018
5-9 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Daiichi Sankyo Nordics ApS - Sweden Filial
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
SL
Sandra Louise Viberg
Audit
Audit
2026
ÅM
Åke Magnus Gisel
Chief Executive Officer
Chief Executive Officer
2022
CV
Christophe Vincent Claude Marie Tiberghien
Chief Executive Officer
Chief Executive Officer
2026
Former (3)
NT
Nicola Torosantucci
Chief Executive Officer
Chief Executive Officer
2020 – 2022
PJ
Patrik Josef Grandits
Chief Executive Officer
Chief Executive Officer
2020 – 2020
ÅM
Åke Magnus Gisel
Chief Executive Officer
Chief Executive Officer
2022 – 2026
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Daiichi Sankyo Nordics ApS - Sweden Filial
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
